Pharma fever may recede as Covid wanes

ET Intelligence Group: One of the upticks of the Covid-ridden stock market was the revival of sentiment in pharma stocks. The sector that had peaked out on the bourses in 2015 saw buying interest due to the focus on healthcare. However, the interest is likely to wane as Covid recedes. 1. One-time boost from Covid drug salesThe brisk sale of Covid drugs provided an exceptional boost to the domestic sales of companies such as Cipla and Glenmark.